Access to anti-retroviral drugs, male in IDA total
IDA total: Access to anti-retroviral drugs, male was 78.2% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in IDA total, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in IDA total stood at 78.2%. That is the highest value across all 25 years on record.
That represents a change of up 4.9% on the previous year and up 115.5% over ten years.
Over the whole period, access to anti-retroviral drugs, male in IDA total peaked at 78.2% in 2024 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in IDA total, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.1% | — |
| 2002 | 0.1% | +30.0% |
| 2003 | 0.4% | +366.0% |
| 2004 | 1.8% | +305.5% |
| 2005 | 3.7% | +107.9% |
| 2006 | 6.7% | +81.2% |
| 2007 | 10.3% | +54.0% |
| 2008 | 14.6% | +41.2% |
| 2009 | 18.7% | +28.5% |
| 2010 | 21.9% | +17.0% |
| 2011 | 24.8% | +13.2% |
| 2012 | 27.8% | +12.0% |
| 2013 | 32.1% | +15.7% |
| 2014 | 36.3% | +12.9% |
| 2015 | 40.8% | +12.5% |
| 2016 | 45.5% | +11.6% |
| 2017 | 51.3% | +12.8% |
| 2018 | 54.5% | +6.1% |
| 2019 | 59.1% | +8.6% |
| 2020 | 63.9% | +8.0% |
| 2021 | 67.3% | +5.4% |
| 2022 | 71.7% | +6.6% |
| 2023 | 74.5% | +3.9% |
| 2024 | 78.2% | +4.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.6% | 0.0% | 18.7% | 10 |
| 2010s | 39.4% | 21.9% | 59.1% | 10 |
| 2020s | 71.1% | 63.9% | 78.2% | 5 |
Countries ranked near IDA total
More gender data for IDA total
- Labor force, female 308.79 million (2025)
- Labor force, female, per capita 0.1554 units per person (2025)
- Labor force, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2.69 % change on previous year (2025)
- Labor force, female, per square kilometre 11.72 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 0.5731 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.3525 per 1,000 uninfected male population ages 15-49 (2024)
- Incidence of HIV, ages 15-24, female 0.7217 per 1,000 uninfected female population ages 15-24 (2024)
- Incidence of HIV, ages 15-24, male 0.2779 per 1,000 uninfected male population ages 15-24 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 120.1% (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in IDA total?
- Access to anti-retroviral drugs, male in IDA total was 78.2% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in IDA total?
- The highest recorded value was 78.2% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in IDA total?
- The lowest recorded value was 0.0% in 2000.
- How does IDA total rank for access to anti-retroviral drugs, male?
- IDA total ranks 11th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in IDA total?
- Over the last ten years it is up 115.5%. The long-run trend across the full record is volatile.
- Where does this IDA total data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.